2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole
CAS: 1613695-14-9
Ref. 3D-NPC69514
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Informação sobre produto
2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole (DCPI) is a cancer drug that inhibits the activity of DNA topoisomerase II. It is used to treat cancers that are resistant to other cancer drugs. DCPI is a potent inhibitor of DNA topoisomerase II and has been shown to be effective in treating multiple myeloma and acute lymphoblastic leukemia. DCPI binds to the active site of DNA topoisomerase II and prevents its cleavage of dsDNA, which leads to cell death by preventing the synthesis of proteins essential for cell division.
Propriedades químicas
Consulta técnica sobre: 3D-NPC69514 2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.